Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular formsRubinsky-Elefant, G. ; Hirata, C. E. ; Yamamoto, J. H. ; Ferreira, M. U.Annals of allergy, asthma, & immunology, 2010-01, Vol.104 (1), p.3-23 [Periódico revisado por pares]Leeds: Taylor & FrancisTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Use of Receiver Operating Curve Analysis and Machine Learning With an Independent Dose Calculation System Reduces the Number of Physical Dose Measurements Required for Patient-Specific Quality AssuranceHasse, K. ; Scholey, J. ; Ziemer, B.P. ; Natsuaki, Y. ; Morin, O. ; Solberg, T.D. ; Hirata, E. ; Valdes, G. ; Witztum, A.International journal of radiation oncology, biology, physics, 2021-03, Vol.109 (4), p.1086-1095 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Toxocariasis: critical analysis of serology in patients attending a public referral center for ophthalmology in BrazilRubinsky-Elefant, Guita ; Yamamoto, Joyce H. ; Hirata, Carlos E. ; Prestes-Carneiro, Luiz E.Japanese journal of ophthalmology, 2018-01, Vol.62 (1), p.77-83 [Periódico revisado por pares]Tokyo: Springer JapanTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
TLR2 and TLR4 expression after kidney ischemia and reperfusion injury in mice treated with FTY720Pedregosa, J.F. ; Haidar, A.A. ; Hirata, A.E. ; Franco, M. ; Gomes, G.N. ; Bueno, V.International immunopharmacology, 2011-09, Vol.11 (9), p.1311-1318 [Periódico revisado por pares]Kidlington: Elsevier B.VTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
OC-0693 Virtual VMAT QA prospective validation: towards measurement-free patient-specific quality assuranceWall, P. ; Hirata, E. ; Morin, O. ; Valdes, G. ; Witztum, A.Radiotherapy and oncology, 2021-08, Vol.161, p.S545-S547 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
1678P The interaction between cancer cells and cancer-associated fibroblasts promotes RAS signalling in squamous cell carcinoma, resulting in an immune-suppressive tumour microenvironment and poorer survival outcomesRullan, A.J. ; Giangreco, G. ; Naito, Y. ; Hooper, S. ; Chakravarty, P. ; Hirata, E. ; Harrington, K.J. ; Sahai, E.Annals of oncology, 2022-09, Vol.33, p.S1309-S1310 [Periódico revisado por pares]Texto completo disponível |
7 |
Material Type: Artigo
|
![]() |
PO-1297 Machine Learning Identifies Predicators of Disease-Free Survival in Patients with Cervical CancerYoshida, E. ; Arbelo Gonzalez, W. ; Valdes, G. ; Hirata, E. ; Morin, O. ; Hsu, I.Radiotherapy and oncology, 2021-08, Vol.161, p.S1067-S1068 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Angiotensin II induces superoxide generation via NAD(P)H oxidase activation in isolated rat pancreatic isletsHirata, A.E. ; Morgan, D. ; Oliveira-Emilio, H.R. ; Rocha, M.S. ; Carvalho, C.R.O. ; Curi, R. ; Carpinelli, A.R.Regulatory peptides, 2009-02, Vol.153 (1), p.1-6 [Periódico revisado por pares]Kidlington: Elsevier B.VTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Lanceocrepidiasides A–F, glucosides of guaiane-type sesquiterpene from Crepidiastrum lanceolatumTakeda, Yoshio ; Masuda, Toshiya ; Morikawa, Hiroyuki ; Ayabe, Hisako ; Hirata, Eiji ; Shinzato, Takakazu ; Aramoto, Mitsunori ; Otsuka, HideakiPhytochemistry (Oxford), 2005-03, Vol.66 (6), p.727-732 [Periódico revisado por pares]Amsterdam: Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
PO-1362: Experience with an independent patient QA dose calculation system in multi-linac and TPS environmentWitztum, A. ; Ziemer, B.P. ; Hasse, K. ; Natsuaki, Y. ; Valdes, G. ; Hirata, E. ; Solberg, T.D. ; Scholey, J.Radiotherapy and oncology, 2020-11, Vol.152, p.S722-S723 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |